Abstract
The cancer preventing effect of flavonoids is largely documented in literature. In addition to their nutritional value as cancer preventing agents, they have been studied as drug candidates in cancer treatment. Many mechanisms of action have been identified, including carcinogen inactivation, antiproliferation, cell cycle arrest, induction of apoptosis and differentiation, inhibition of angiogenesis, antioxidative activity and reversal of multidrug resistance. The diversity in the biological targets of flavonoids has led during the last twenty years to an extensive research toward medicinal chemistry of flavonoids with the aim to obtain anticancer drugs. Some anticancer agents derived from flavonoids are emerging as major anticancer drugs or chemosensitizers. This review will shed light on recent molecules obtained from efforts made on medicinal chemistry of flavonoids. A special focus will be made on flavonoid derivatives being studied in clinical trials.
Keywords: Anticancer potential, Clinical trials, Drug candidates, Flavonoids, Structural analog, radical-scavenging, ion-chelating abilities, reactive oxygen species (ROS), cytochrome P450, apoptosis, antiproliferation, angiogenic processes, structure-activity relationship (SAR), adenine moeity, isoflavones
Current Organic Chemistry
Title: Flavonoids as Anticancer Agents: Recent Progress and State of the Art?
Volume: 15 Issue: 15
Author(s): Estelle Genoux, Edwige Nicolle and Ahcene Boumendjel
Affiliation:
Keywords: Anticancer potential, Clinical trials, Drug candidates, Flavonoids, Structural analog, radical-scavenging, ion-chelating abilities, reactive oxygen species (ROS), cytochrome P450, apoptosis, antiproliferation, angiogenic processes, structure-activity relationship (SAR), adenine moeity, isoflavones
Abstract: The cancer preventing effect of flavonoids is largely documented in literature. In addition to their nutritional value as cancer preventing agents, they have been studied as drug candidates in cancer treatment. Many mechanisms of action have been identified, including carcinogen inactivation, antiproliferation, cell cycle arrest, induction of apoptosis and differentiation, inhibition of angiogenesis, antioxidative activity and reversal of multidrug resistance. The diversity in the biological targets of flavonoids has led during the last twenty years to an extensive research toward medicinal chemistry of flavonoids with the aim to obtain anticancer drugs. Some anticancer agents derived from flavonoids are emerging as major anticancer drugs or chemosensitizers. This review will shed light on recent molecules obtained from efforts made on medicinal chemistry of flavonoids. A special focus will be made on flavonoid derivatives being studied in clinical trials.
Export Options
About this article
Cite this article as:
Genoux Estelle, Nicolle Edwige and Boumendjel Ahcene, Flavonoids as Anticancer Agents: Recent Progress and State of the Art?, Current Organic Chemistry 2011; 15 (15) . https://dx.doi.org/10.2174/138527211796367363
DOI https://dx.doi.org/10.2174/138527211796367363 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cross Bridging Proteins in Nature and their Utilization in Bio- and Nanotechnology
Current Protein & Peptide Science The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry Computational Methods and Algorithms for Mass Spectrometry Based Differential Proteomics: Recent Advances, Perspectives and Open Problems
Current Proteomics Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects
Current Drug Metabolism Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen
Current Pharmaceutical Design Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Do Drugs Work for ΟΑΒ Following Prostate Cancer Surgery
Current Drug Targets In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design Eplerenone, a New Selective Aldosterone Blocker
Current Pharmaceutical Design Multicomponent Reactions in Antimitotic Drug Discovery
Current Topics in Medicinal Chemistry